| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |